Works matching DE "DURATA Therapeutics Inc."
Results: 3
$675 million for MRSA antibiotic.
- Published in:
- Nature Biotechnology, 2014, v. 32, n. 11, p. 1070, doi. 10.1038/nbt1114-1070c
- Publication type:
- Article
News in brief.
- Published in:
- Nature Reviews Drug Discovery, 2010, v. 9, n. 2, p. 93, doi. 10.1038/nrd3108
- Publication type:
- Article
First QIDP drug approved, but designation may fail urgent needs.
- Published in:
- Nature Medicine, 2014, v. 20, n. 7, p. 690, doi. 10.1038/nm0714-690
- By:
- Publication type:
- Article